Thrombasthenia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2023-02-27
EMA Authorised: NovoSeven (eptacog alfa (activated)) — Novo Nordisk A/S
The EMA authorised NovoSeven (eptacog alfa activated) from Novo Nordisk A/S for multiple indications including Hemophilia A/B, Factor VII de…